Pharmaceutical and biotech companies license our technology platforms including PER.C6®, AdVac®, and STAR® for the production of a wide range of products. Our proprietary technologies enable the discovery, development and production of vaccines, antibodies and therapeutic proteins, and gene therapy products.
Crucell is also interested in partnering with companies for its drug discovery and product development pipeline. Through these relationships, Crucell leverages its development expertise in the product development life cycle.
Furthermore, Crucell has a strong set of alliances for the marketing and sales of Crucell’s own products. Crucell also partners to market and distribute third party products.
Partnering with other companies is of strategic importance to Crucell. Whether it is a strategic alliance, a licensing agreement or a marketing and sales alliance, Crucell works closely with our partners to ensure success for both organizations.